文献速递血液净化与透析慢性肾脏病水电解质与酸碱

非糖尿病血液透析患者血清甘油-3-磷酸与成纤维细胞生长因子23的关联

Association between Serum Glycerol-3-Phosphate and Fibroblast Growth Factor-23 in Nondiabetic Patients on Hemodialysis.
PubMed 文献 · Clin J Am Soc Nephrol · 2025-10-17

该横断面研究纳入99例非糖尿病血液透析终末期肾病患者,分析血清甘油-3-磷酸(G3P)三分位与对数转换C端FGF23的关联。结果显示最高G3P三分位者FGF23水平较低三分位者高95%(95%CI 6%–260%,P=0.04),磷酸戊糖途径介导该关系(β系数变化62%)。

要点

  • 非糖尿病血透患者中血清G3P升高与C端FGF23升高独立相关。
  • 磷酸戊糖途径是G3P与FGF23关系的主要介导通路。
  • G3P或为CKD-矿物质骨异常(CKD-MBD)的潜在干预靶点。

核心结论

  • 在非糖尿病血液透析的ESKD患者中,血清G3P与血清C端FGF23正相关,且该关系由磷酸戊糖途径介导。

研究设计与样本

  • 横断面研究,纳入99例非糖尿病ESKD血液透析患者;采用线性回归分析G3P三分位与对数转换C端FGF23的关联,并用通路富集与中介分析探讨机制。

主要发现

  • 参与者中位年龄54岁(IQR 44–63),38%为女性,71%自认黑人,27%有冠心病,中位FGF23为777(IQR 222–1310)RU/ml。
  • 校正人口学、冠心病、血钙、血磷及甲状旁腺激素后,最高G3P三分位者FGF23水平较低三分位者高95%(95%CI 6%–260%,P=0.04)。
  • 247种血清代谢物中27种与FGF23显著相关(P<0.01),通路富集首位为磷酸戊糖途径(impact score=0.33,FDR校正P=0.01)。
  • 磷酸戊糖途径介导G3P与FGF23的关系,使β系数变化62%。

临床怎么用

  • G3P与磷酸戊糖途径可能成为ESKD患者CKD-MBD的机制研究与治疗靶点探索方向。

局限性

  • 横断面设计无法推断因果;样本量99例、仅非糖尿病血透患者,结论外推受限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

KEY POINTS: Serum glycerol-3-phosphate (G3P) levels were significantly associated with higher fibroblast growth factor 23 levels in ESKD. Pathway and mediation analyses identified the pentose phosphate pathway as the top mediator of the relationship between serum G3P and fibroblast growth factor 23. The role of G3P in ESKD provides new insights into potential therapeutic targets for CKD-mineral and bone disorder. BACKGROUND: Fibroblast growth factor 23 (FGF23) is a key regulator of mineral metabolism that is independently associated with mortality in patients with ESKD. Glycerol-3-phosphate (G3P), a byproduct of glycolysis that can be derived from injured kidneys, stimulates FGF23 production. We aimed to determine if serum G3P is associated with FGF23 levels in patients with ESKD and identify potential molecular pathways that mediate their relationship. METHODS: We conducted a cross-sectional study of 99 nondiabetic patients with ESKD on hemodialysis. We used linear regression to examine the association between G3P terciles and log-transformed C-terminal FGF23 levels, adjusting for demographics, coronary artery disease, serum calcium, phosphorus, and parathyroid hormone. Mann–Whitney U tests compared 247 serum metabolite levels between the first and third FGF23 terciles; significant metabolites (P < 0.01) were selected for pathway enrichment analyses. Top pathway scores were used in mediation analyses. RESULTS: The median age of participants was 54 years (interquartile range [IQR], 44–63), 38% were women, 71% self-identified as Black, and 27% had coronary artery disease. The median FGF23 level was 777 (interquartile range, 222–1310) RU/ml. In adjusted analyses, compared with participants with the lowest G3P tercile, those with the highest G3P tercile had a 95% higher FGF23 level (95% Confidence Interval, 6% to 260%; P = 0.04). Of the 27 metabolites significantly associated with FGF23 levels, pathway enrichment analysis identified the pentose phosphate pathway as the top hit (impact score=0.33, false discovery rate-adjusted P value = 0.01). The pentose phosphate pathway mediated the relationship between G3P and FGF23, resulting in a 62% change in the β coefficient. CONCLUSIONS: In nondiabetic patients with ESKD on hemodialysis, serum G3P positively correlated with serum C-terminal FGF23, and this relationship was mediated by the pentose phosphate pathway. Exploring the pentose phosphate pathway could yield critical mechanistic insights into the regulation of FGF23, enhancing our understanding of its broader biologic functions.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Wilson SM, Zaslow S, Sozio SM, et al. Association between Serum Glycerol-3-Phosphate and Fibroblast Growth Factor-23 in Nondiabetic Patients on Hemodialysis. Clin J Am Soc Nephrol. 2025. PMID: 41105473. doi:10.2215/CJN.0000000871

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。